序号 |
标题 |
次数 |
作者 |
发布时间 |
76006 |
CAS 1438853-35-0:Mal-PEG3-Val-Cit-PAB-PNP |
69 |
WYQ |
2024-12-19 |
76007 |
N-(Methyltetrazine-PEG4)-amido-PEG8-3,4-dithiophenolmaleimide |
103 |
zyl |
2024-12-19 |
76008 |
MC-beta-Ala-alpha-GlcA-MMAE,ADC定制 |
110 |
wyh |
2024-12-19 |
76009 |
Mal-PEG2-Val-Cit-PAB-OH(CAS: 2055041-38-6) |
77 |
WYQ |
2024-12-19 |
76010 |
cas:2100306-78-1,t-Butyl 3-(hydroxypropoxyl)-propanoate |
90 |
zyl |
2024-12-19 |
76011 |
NHS ester-PEG4-VC-PAB-Daunorubicin,ADC定制 |
76 |
wyh |
2024-12-19 |
76012 |
Mal-PEG3-Val-Cit-PAB-OH(CAS: 2727965-49-1) |
106 |
WYQ |
2024-12-19 |
76013 |
cas:1539292-60-8,tert-butyl 3-(4-(2-cyanoethynyl)phenylcarbamoyl)propylcarbamate |
65 |
zyl |
2024-12-19 |
76014 |
1281816-04-3,Lys-Nε-MCC-DM1,ADC定制 |
69 |
wyh |
2024-12-19 |
76015 |
cas:34450-18-5,Alkynyl Stearic Acid,17-十八炔酸 |
122 |
zyl |
2024-12-19 |
76016 |
Mal-PEG4-Val-Cit-PAB-OH(CAS: 2055041-39-7) |
113 |
WYQ |
2024-12-19 |
76017 |
1281816-04-3,Lys-Nε-MCC-DM1,ADC定制 |
72 |
wyh |
2024-12-19 |
76018 |
cas:120550-35-8,Biotin-PFP ester,五氟苯酚生物素酯 |
225 |
zyl |
2024-12-19 |
76019 |
MTS-ADO3A 三酸DOTA衍生物 |
104 |
h |
2024-12-19 |
76020 |
NHS-PEG2-NH-Xanomeline,ADC定制 |
87 |
wyh |
2024-12-19 |
76021 |
DOTA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 DOTA-CCK |
124 |
h |
2024-12-19 |
76022 |
DOTA-MN2 2,2’-[4,10-双(2-{[2-(2-甲基-5-硝基-1H-咪唑-1-基)乙基]氨基}-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1,7-二基]二乙酸 |
79 |
h |
2024-12-19 |
76023 |
cas:2123482-78-8,TETRAZINE-SS-BIOTIN 四嗪-双硫键-生物素 |
71 |
zyl |
2024-12-19 |
76024 |
GG-Tesirine,ADC定制 |
114 |
wyh |
2024-12-19 |
76025 |
DOTA-PEG-A20FMDV2 DOTA偶联聚乙二醇化的20个残基的线性肽 |
151 |
h |
2024-12-19 |
76026 |
MC-GGFG-Exatecan,ADC定制 |
139 |
wyh |
2024-12-19 |
76027 |
亲和素-AMF-DOTA(Nd) |
103 |
h |
2024-12-19 |
76028 |
DOTA偶联人血清白蛋白微球 DOTA-HSAM |
139 |
h |
2024-12-19 |
76029 |
MC-VA-PBD,MC-Val-Ala-PBD,ADC定制 |
197 |
wyh |
2024-12-19 |
76030 |
cas:2241685-22-1,DADPS Biotin Alykne |
93 |
zyl |
2024-12-19 |
76031 |
MC-vc-PAB-C6-Alpha-Amanitin,ADC定制 |
75 |
wyh |
2024-12-19 |
76032 |
MPB-MMAF,ADC定制 |
129 |
wyh |
2024-12-19 |
76033 |
DOTA–Bipy–RuII配位共轭物 |
145 |
h |
2024-12-19 |
76034 |
cas:1007215-91-9,1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oic acid |
112 |
zyl |
2024-12-19 |
76035 |
DOTA-cT84.66 DOTA偶联单克隆抗体cT84.66 |
88 |
h |
2024-12-19 |
76036 |
DOTA-Ahx-(D-Lys(6)-GnRH1)金属螯合剂DOTA偶联氨基己酸缀合D-赖氨酸 |
94 |
h |
2024-12-19 |
76037 |
DOTA-LRB 2-(6-(二乙基氨基)-3-(二乙基亚胺基)-3H-呫吨-9-基)-5-(N-(2-(2-(4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基)乙酰胺基 |
96 |
h |
2024-12-19 |
76038 |
DOTA-Y3-TATE DOTA偶联激动剂Y3-TATE |
86 |
h |
2024-12-19 |
76039 |
DOTA-2-脱氧-D-氨基葡萄糖 DOTA-DG |
133 |
h |
2024-12-19 |
76040 |
DOTA-c(RGDfK)DOTA偶联环肽 |
89 |
h |
2024-12-19 |
76041 |
SCN-DOTA-PCA DOTA-苯甲酰胺衍生物 |
108 |
h |
2024-12-19 |
76042 |
DOTA-N-羟基琥珀酰亚胺 DOTA-N-hydroxysuccinimide |
92 |
h |
2024-12-19 |
76043 |
低分子量CLT1肽靶向Gd(III)螯合物CLT1-dL-(Gd-DOTA) |
159 |
h |
2024-12-19 |
76044 |
DOTA-1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺脂质 |
150 |
h |
2024-12-19 |
76045 |
1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA17,19) |
105 |
h |
2024-12-19 |
76046 |
cas:1061569-06-9,4-formyl-N-(2-(2-hydroxyethoxy)ethyl)benzamide ADC抗体偶联药物 |
81 |
zyl |
2024-12-19 |
76047 |
DBCO-PEG4-VA-PBD,2241644-09-5,ADC定制 |
76 |
wyh |
2024-12-19 |
76048 |
Val-Cit-PAB-MMAE,cas:644981-35-1,ADC定制 |
83 |
wyh |
2024-12-19 |
76049 |
DOTA-GMSH 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)偶联α-黑素细胞刺激素(α-MSH)类似物 |
103 |
h |
2024-12-19 |
76050 |
mDPR-Val-Cit-PAB-MMAE,1491152-26-1,ADC定制 |
82 |
wyh |
2024-12-19 |